ICD-10-CM Billable Code

T42.1

Poisoning by, adverse effect of and underdosing of iminostilbenes

Clinical Classification Guidelines

Inclusion Terms

  • Poisoning by, adverse effect of and underdosing of carbamazepine

Medical Intelligence & Overview

ICD-10 Code T42.1 refers to cases involving poisoning, adverse effects, or underdosing of iminostilbenes, primarily focusing on carbamazepine. These medications are used to manage neurological conditions such as epilepsy and certain mood disorders. While effective, they can cause adverse reactions if misused, leading to various health complications. Recognizing the risks associated with these drugs is essential for healthcare providers and patients alike.

Causes & Symptoms

Clinical Causes: Incorrect dosage or accidental overdose of carbamazepine Use of carbamazepine beyond prescribed limits Concurrent use of interacting medications that increase carbamazepine levels Unintentional ingestion, particularly in children Sensitivity or allergic reactions to iminostilbenes

Key Symptoms: Dizziness or lightheadedness Nausea and vomiting Drowsiness or fatigue Blurred vision Unsteady gait or coordination problems Respiratory depression in severe cases Altered mental state, including confusion or agitation Tremors or muscle stiffness Skin rash or allergic reactions Seizures or convulsions in severe poisoning

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Healthcare providers typically assess the patient's history of medication intake, symptoms, and potential exposure. Blood tests measuring carbamazepine levels help determine if the drug concentration is above therapeutic ranges. Additional tests might include liver function panels and other assessments to evaluate organ involvement and toxicity levels. Imaging or neurological evaluations may be performed if complications such as seizures or altered mental state occur.

Treatment Protocols: Treatment strategies focus on managing symptoms and removing or neutralizing the toxic effects of the drug. Approaches may include: - **Supportive care**: Ensuring airway stability, breathing, and circulation. - **Activated charcoal**: Administered if the poisoning is recent to reduce drug absorption. - **Enhanced elimination**: In severe cases, techniques like hemodialysis may be employed to remove carbamazepine from the bloodstream. - **Specific antidotes**: While no specific antidote exists for carbamazepine overdose, benzodiazepines might be used to treat seizures. - **Monitoring and supportive interventions**: Continuous observation of vital signs, neurological status, and organ function. - **Adjusting medication regimen**: Once stabilized, adjusting the patient's medication plan to prevent recurrence.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T42.1 a billable ICD-10 code?
Yes, T42.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T42.1?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of iminostilbenes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference